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Perinatal infections have a negative impact on brain development. However, the underlying mechanisms leading to neurological
impairment are not completely understood and reliable models of inflammation are urgently needed. Using phorbol-myristate-
acetate as an activator of inflammation, we investigated the effect on the developing rodent brain. Neonatal rats and mice deficient
in IL-18 or IRAK-4 were exposed to PMA. Brains were assessed for regulation of pro- and anti-inflammatory cytokines and cell
death 24 hrs, 7 and 14 days after treatment. PMA induced an inflammatory response and caused widespread neurodegeneration in
the brains of 3- and 7-day-old rats. In contrast, 14-day-old rats were resistant to the neurotoxic effect of PMA.Histological evaluation
at the age of 14 and 21 days revealed a destruction of the cortical microstructure with decreased numerical density of neuronal cells.
Mice deficient in IL-18 or IRAK-4 were protected against PMA induced brain injury. PMA treatment during a vulnerable period
can alter brain development. IL-18 and IRAK-4 appear to be important for the development of PMA induced injury.
1. Introduction
Recent advances in the understanding of fetal physiology and
neonatal intensive care medicine have resulted in markedly
increased survival rates of premature infants.However, severe
motor and cognitive impairment still affects a considerable
proportion of surviving patients, who exhibit disturbances in
learning, cognition, and attention [1]. Whereas many of these
disabilities have been attributedmostly towhitematter injury,
disrupted greymatter development also appears to contribute
to disabilities of preterm survivors [2]. Brain injury with
widespread loss of neurons has been noted in the cortex,
hippocampus, and thalamus of postmortem specimens from
patients with periventricular leukomalacia (PVL) [3]. How-
ever, the pathology of perinatal brain injury is complex and
depends on injury mode and developmental stage [4]. Over
the last decade the hypoxic-ischemic paradigm for neonatal
brain injury has been replaced by a multifactorial hypothesis
which recognizes the key role elevated levels of proinflamma-
tory cytokines play in systemic inflammation of the brain [5].
In previous studies, we induced inflammation by hyperoxia
in combination with lipopolysaccharide (LPS) and identified
the role of inflammatory cytokines in neurodegenerative
processes in the developing brain [6, 7]. These inflammatory
mediators trigger strong alterations in brain development
and changes in microstructural integrity [7]. Furthermore,
an increase in degenerating cells in the thalamus of newborn
rabbits prenatally exposed to endotoxins suggests impair-
ment of grey matter [8].
T-cell activation is a fundamental step for an effective
immune response and is triggered by the interaction of recep-
tors to specific ligands with concomitant formation of diacyl-
glycerol and activation of protein kinase C (PKC). PMA, a
structural analogue of diacylglycerol, is a potent activator of
PKC [9]. Activation of PKC by PMA results in the induction
Hindawi Publishing Corporation
BioMed Research International
Volume 2015, Article ID 318306, 9 pages
http://dx.doi.org/10.1155/2015/318306
2 BioMed Research International
of granulocytes, proinflammatory cytokines like IL-6, TNF-
𝛼, IL-1𝛽, increased levels of glutamate, and the release of
reactive oxygen species [10, 11]. In the developing rodent
brain, IL-1𝛽 and IL-18 play a pivotal role in inflammatory
responses with subsequent cell death [6, 7, 12]. Engagement
of IL-1𝛽 and IL-18 receptors initiates a common intracellular
signaling cascade wherein the myeloid differentiation factor
(MyD88) and TNF receptor associated factor 6 (TRAF6)
serve as key adaptor proteins. It has been shown that IRAK-
4 mediates signaling between MyD88 and TRAF6 thereby
providing an essential component in promoting downstream
signals. Nevertheless the complex mechanisms of inflamma-
tion leading to brain injuries are still controversial and remain
unclear. Seeking to better understand the histological injury
patterns and pathways involved in inflammatory neonatal
brain injuries, we applied PMA as an inflammatory trigger
to neonatal rodents. By administering PMA to IRAK-4 and
IL-18 knockout mice we provide additional evidence that
disruption of inflammatory pathways is sufficient to protect
the developing brain from PMA induced injury.
2. Materials and Methods
2.1. Animals and Drug Administration. All animal exper-
iments were carried out in accordance with institutional
guidelines and conform to the EuropeanGuidelines forUse of
Experimental Animals by FELASA (Federation of European
Laboratory Animal Science Association) and were approved
by the local animal research committee. 2-, 6- and 13-day-
old randomly assigned male Wistar rat pups (BgVV, Berlin,
Germany) received a single intraperitoneal (i.p.) injection
of vehicle (normal saline, Braun, Ingelheim, Germany) or
PMA (500 𝜇g/kg, Sigma, St. Louis, USA). A subgroup of 6-
day-old rat pups received a single injection of vehicle or
different PMA doses (100, 200, and 500 𝜇g/kg). Animals were
sacrificed 24 hours or 7 and 14 days following PMA exposure.
6-day-old homozygous IRAK-4-deficient C57BL/6 mice
(provided by Dr. Yeh, Ontario Cancer Institute, Toronto,
Canada) and Interleukin-18-deficient C57BL/6 mice
(B6.129P2-Il18tm1Aki/J, Jackson Laboratory, Bar Harbor,
USA) received a single injection of PMA (200 𝜇g/kg). Wild-
type mice serving as controls received either PMA or vehicle.
All pups were kept with their dams except for injections to
avoid hypothermia and malnutrition.
2.2. Tissue Sampling. Animals subjected to histological anal-
ysis received an overdose of chloral-hydrate and were tran-
scardially perfused with 0.1M phosphate-buffered saline
followed by 4% paraformaldehyde in cacodylate buffer solu-
tion. Coronal paraffin sections (10 𝜇m, microtome HM 360;
Microm, Giessen, Germany) were stained with cresyl violet
to determine total cell density in P14 and P21 animals. For
real-timePCRanalysis, animalswere decapitated, brainswere
immediately removed, and hemispheres were snap frozen in
liquid nitrogen and stored at −80∘C until analysis.
2.3. RNA Extraction and Semiquantitative Real-Time
PCR. Total RNA was isolated from snap-frozen tissue by
acidic phenol/chloroform extraction (peqGOLD RNAPure;
PEQLAB Biotechnologie, Erlangen, Germany) and 2 𝜇g
of RNA was reverse transcribed. The PCR products
of IL-1𝛽, TNF-𝛼, TGF-𝛽1, and hypoxanthine-gua-
nine phosphoribosyltransferase (HPRT, as internal standard)
were quantified in real time, using dye-labeled fluorogenic
reporter oligonucleotide probes and primers (Metabion,
Munich, Germany) with the following sequences and cor-




(NM 012675) sense 5󸀠-TCGAGTGACAAGCCCGTAGC-3󸀠,
antisense 5󸀠-CTCAGCCACTCCAGCTGCTC-3󸀠, probe
5󸀠-CGTCGTAGCAAACCACCAAGCAGA-3󸀠; TGF-𝛽1
(NM 021578) sense 5󸀠-CCCTGCCCCTACATTTGGA-3󸀠,
antisense 5󸀠-ACGGTGATGCGGAAGCAC-3󸀠, probe
5󸀠-CACACAGTACAGCAAGGTCCTTGCCCT-3󸀠;
HPRT (NM 012583) sense 5󸀠-GGAAAGAACGTCTTGATT-
GTTGAA-3󸀠, antisense 5󸀠-CCAACACTTCGAGAGGT-
CCTTTT-3󸀠, probe 5󸀠-CTTTCCTTGGTCAAGCAG-
TACAGCCCC-3󸀠. All probes were labeled at their 5󸀠
ends with the reporter dye 6-carboxy-fluoresceine (FAM)
and at their 3󸀠 ends with the quencher dye 6-carboxy-
tetramethylrhodamine (TAMRA). Real-time PCR and
detection were performed in triplicate and repeated 3 times
for each sample using a total reactive volume of 13 𝜇L which
contained 6.5 𝜇L of 2x TaqMan Universal PCR Master Mix
(Applied Biosystems, Foster City, USA), 2.5𝜇L of 1.25𝜇M
oligonucleotide mix, 0.5 𝜇L (0.5𝜇M) of probe, and 50 ng of
cDNA template. The PCR amplification was performed in
96-well optical reaction plates for 40 cycles with each cycle
at 94∘C for 15 s and 6∘C for 1min. The expression of IL-1𝛽,
TNF-𝛼, TGF-𝛽1, and HPRT was analyzed with the real-time
PCR ABI Prism 7500 sequence detection system (Applied
Biosystems) according to the 2−ΔΔCT method [13].
2.4. De Olmos Cupric Silver Staining. Brains were embedded
in agar; coronal sections (70𝜇m) were cut and processed
for staining with silver and cupric nitrate according to the
method of De Olmos and Ingram [14]. Degenerating cells
were identified by a distinct dark appearance due to silver
impregnation.
2.5. Fluoro-Jade B Staining. Paraffin sections were incubated
for 10min in 0.06% solution of potassium permanganate
and stained for 20min in 0.0004% solution of fluoro-jade B
(Histo-Chem, Jefferson, USA) dissolved in 0.1% acetic acid.
Sections were coverslipped with nonfluorescent mounting
media (Sigma) and samples were examined with an epifluo-
rescent microscope using blue light (excitation 450–490 nm,
emission 515–565 nm). Degenerating cells were identified by
a green fluorescent appearance.
2.6. TUNEL Staining. Staining was performed on paraffin
sections using the Apop Tag Peroxidase kit (Oncor Appli-
gene, Heidelberg, Germany) according to the manufacturer’s
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Table 1: Average weight gain in g/day, % survival rate and number of animals used.
















1.0 ± 0.2 1.3 ± 0.1 1.0 ± 0.2 1.4 ± 0.2 1.3 ± 0.2 1.4 ± 0.2 0.5∗∗ ± 0.1 1.4 ± 0.2 0.7∗∗∗ ± 0.1 2.8 ± 0.2
% survival 100 100 88 100 100 100 91 100 100 100
𝑛 = 11 10 7 8 9 8 10 8 8 5
P7 and P14 rats treated with PMA 500𝜇g/kg showed impaired weight gain 24 hours after injection compared to their control littermates (±SEM, ∗∗𝑃 < 0.01;
∗∗∗
𝑃 < 0.001, Student’s 𝑡-test).
instructions. Sections were finally stained with diaminoben-
zidine (Sigma) and TUNEL positive cells were identified by
brown appearance.
2.7. Immunohistochemistry for Cleaved Caspase-3. Paraffin
sections were microwaved in 10mM citrate buffer and
endogenous peroxidase activity was blocked with 0.6%
hydrogen peroxide. Slices were incubated with normal goat
serum overnight at 4∘C with anti-cleaved caspase-3 antibody
(1 : 100; Cell Signaling, Frankfurt, Germany). Sections were
treated with rabbit anti-goat IgG. After detection with ABC
kit (Vector Laboratories, Peterborough, UK), positive cells
were visualized with diaminobenzidine.
2.8. Quantification of Neurodegeneration. Degenerating cells
were identified by using De Olmos, cresyl violet (rat), or
fluoro-jade B staining (mice). Mean numerical cell densities
(𝑁V) of degenerating cells or total cell density (cells/mm
3)
were acquired in 17 brain regions by means of a stereological
dissector. An unbiased counting frame (0.05 × 0.05mm, dis-
sector height 0.01mm for fluoro-jade B/cresyl violet, 0.07mm
for silver staining) and a high aperture objective were used for
sampling. Numerical densities (𝑁V) within each brain region
for cell degeneration or total cell density were determined
with eight dissectors [15].The generated cumulative score for
each animal was used for comparison.
2.9. Statistical Analyses. Values are presented as mean ±
SEM. Comparisons among groups were made using one-way
analysis of variance (ANOVA) with Newman-Keul post hoc
test or Student’s 𝑡-test as appropriate. Statistical significance
was determined at 𝑃 < 0.05.
3. Results
3.1. PMAExposureAffects PostnatalWeight Gain. HanWistar
rats treated with PMA (500𝜇g/kg) showed impaired weight
gain compared to control littermates. Average weight gain
was significantly reduced in animals 7 and 14 days old.
Animals receiving a lower dose or are 3 days old showed
adequate weight gain. Survival rate was not altered within
treatment groups (Table 1).
3.2. PMA Triggers mRNA Expression of IL-1𝛽. To determine
how the proinflammatory cytokines IL-1𝛽 andTNF-𝛼 and the
anti-inflammatory cytokine TGF-𝛽1 were affected by PMA
exposure in the neonatal brain, we performed real-time poly-
merase chain reaction (PCR) on mRNA isolated from brain
hemispheres obtained 24 hours after exposure. Quantitative
analysis of mRNA expression revealed a significant increase
of IL-1𝛽 (Figure 1(a)) after PMA exposure (500𝜇g/kg). TNF-
𝛼 and TGF-𝛽1 expression was not affected by PMA therapy
(Figures 1(b) and 1(c)). Control animals and pups treated
with a lower dose (200𝜇g/kg) exhibited no modification of
cytokine expression (Figures 1(a)–1(c)).
3.3. PMA Induces a Robust Neurodegenerative Response in
the Immature Brain. To explore whether a single injection
of PMA exerted neurodegenerative effects, P6 rat pups were
exposed to 500𝜇g/kg PMA. Histological stainings revealed
widespread neurodegeneration (Figures 2(b), 2(d), 2(f), and
2(h)). In age-matched littermates receiving vehicle, degen-
erating cells were sparse (Figures 2(a), 2(c), 2(e), and 2(g)).
Fluoro-jade B, TUNEL, and caspase-3 staining showed a
similar distribution pattern of degenerating cells compared to
silver staining, suggesting apoptosis as a mechanism of PMA
induced cell death. The primary affected brain regions were
the second layer of the cortex, thalamus, and hypothalamus,
as depicted in Figure 3.
3.4. High Dose PMA Induces Neurodegeneration in the Devel-
oping Brain. To Investigate the effects of different doses of
PMA on the immature brain 6-day-old rats were treated with
100, 200, or 500𝜇g/kg PMA. Animals treated with lower
doses of PMA were indistinguishable from control animals.
However, profound neurodegeneration was confirmed after
treatment with 500𝜇g/kg PMA (Figure 4).
3.5. PMA-Induced Neurodegeneration Is Age Dependent. To
determinewhether the apoptotic response to PMAmay differ
as a function of developmental age, we subjected 2-, 6-,
and 13-day-old rats to PMA (500𝜇g/kg). P3 and P7 animals
exposed to PMA revealed enhanced neurodegeneration in
comparison to controls suggesting a timewindowbetween P3
and P7 when neuronal cells are vulnerable to PMA-induced
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Figure 1: Increased expression of proinflammatory cytokine IL-1𝛽 in PMA (500 𝜇g/kg) treated rat pups. ((a)–(c)) Quantitative analysis of
IL-1𝛽, TNF-𝛼, and TGF-𝛽1 mRNA expression at 24 h after PMA administration. Data are normalized to levels of vehicle treated animals
(control = 100%). Values are presented as mean ± SEM. ∗∗𝑃 < 0.01, one-way analysis of variance (ANOVA) with Newman-Keul post hoc test.
cell death. In contrast, P14 rats showed no significant differ-
ence after treatment with PMA in comparison to controls
(Figure 5).
3.6. Neonatal PMAExposure Reduces Neuronal Cell Density in
the Adolescent Rat. In order to investigate whether neonatal
exposure to PMA diminishes the total amount of neuronal
cells and affects cortical cytoarchitecture in older animals, we
administered PMA to 6-day-old rats. Histological evaluation
with cresyl violet staining at the age of 14 and 21 days revealed
a destruction of the cortical microstructure (Figures 6(a)
and 6(b)), with a decreased numerical density of neuronal
cells (Figure 6(c)). The cytoarchitecture in animals exposed
to PMA as a neonate was disorganized, lacking the expected
arrangement of neurons on columns typically seen in the
normal neocortex. These results suggest a long-lasting effect
on brain development by PMA exposure early in life.
3.7. Mice Deficient in IRAK-4 and IL-18 Are Protected against
PMA-Induced Cell Death. To confirm a functional contri-
bution of IL1-𝛽 and IL-18 in PMA-induced cell death, we
injected PMA (200𝜇g/kg) to 6-day-old IRAK-4 and IL-18
knockout mice. Wild-type mice treated with PMA or vehicle
served as controls. Mice receiving a higher dose of PMA
(500𝜇g/kg) did not survive suggesting a higher sensitivity
of mice to PMA. Brains were processed for fluoro-jade B
staining 24 hours later to detect neuronal injury. PMA caused
neuronal cell death in the wild-type mice with a pattern
very similar seen in rats. Vehicle treated wild-type animals
revealed a significant difference compared to PMA treated
littermates. Quantification of cell death in IRAK-4 and IL-
18 knockout mice after PMA exposure displayed a strong
neuroprotective effect compared to PMA treated wild-type
controls (Figure 7).
4. Discussion
Here we describe an activation of the proinflammatory
cytokine IL-1𝛽 and a strong neurodegenerative response in
neonatal rodents after systemic PMA exposure. A single
injection of PMA was sufficient to double the amount of
degenerating cells. The injury pattern was confirmed in



















Figure 2: PMA induced cell death in the immature rat brain. Representative microscopic overviews ((a)–(h), 20x) of affected brain regions.
In the injured frontal cortex from an animal subjected to PMA (500𝜇g/kg), degenerating cells appear as small dark dots in 70𝜇m silver-
stained sections (b), TUNEL staining performed in 10 𝜇m-thick cortical sections of the ventral thalamus confirmsDNA fragmentation within
degenerating cells (d). Fluoro-Jade B staining of the laterodorsal thalamus depicting neurodegenerative changes in P7 rats 24 hours after PMA
exposure (f). Immunohistochemistry demonstrates caspase-3-immunopositive cells in the laterodorsal thalamus of a 7-day-old rat subjected
to PMA ((h), black arrowheads). Photomicrographs of control animals ((a), (c), (e), (g)) showed no neurodegenerative response.










































































































































Figure 3: Graphic illustration of PMA (500𝜇g/kg) induced neu-
rodegeneration in 17 different brain regions of 7-day-old rats.
Degenerating neurons were visualized by De Olmos cupric silver
staining and sampled by the optical dissector method to provide a
numerical density (degenerating cells/mm3).The numerical density
counts were added to give a cumulative score for degenerating cells
for each brain region, and a mean was calculated for each treatment
condition (𝑛 = 8–10 per group). Values are presented as mean ±
SEM. ∗∗∗𝑃 < 0.001, one-way analysis of variance (ANOVA) with
Newman-Keul post hoc test.
different histological stainings suggesting programmed cell
death as a major component of the injury. Impairment of
weight gain seems not to play a pivotal role in PMA induced
neurotoxicity because older animals were not affected despite
the fact that weight gain was significantly depressed. Further-
more, we found the neurotoxic effect of PMA to be confined
to the first postnatal week of life. The first postnatal week of
life is characterized by rapid brain growth and these results
confirm the vulnerability of the neonatal brain during this
growth spurt [16]. PMA treatment predominantly affected
the second cortical layer and the laterodorsal thalamus but
all investigated areas exhibited degenerated cells. Prenatal
endotoxin exposure in rabbits revealed similar results with
a profound decrease of neurons in the anterior thalamus [8].
In addition, neurodegeneration in the thalamus is combined
with a decrease of dendritic arborization in the retrosplenial
cortex suggesting an increased vulnerability of this important
relay station [8].
From human data, it is known that the thalamus is
commonly affected in patients with cerebral palsy, and
atrophy of deep grey matter has previously been described
in patients with PVL [2]. This contrasts to hypoxia-ischemia
in a preterm ovine model, which also revealed an immature
dendritic arborization without detected neuronal cell death,
underlining the specific role of inflammation in neonatal
brain injury and the importance of the mode of injury [17].
Interestingly, animals treated with PMA had a lower total
density of neuronal cells with transformation of the cortical



















Figure 4: Graphic illustration of neurodegeneration in 7-day-old
rats following different doses of PMA (100, 200, and 500 𝜇g/kg).
Degenerating neurons were visualized by De Olmos cupric silver
staining and sampled by the optical dissector method to provide
a numerical density (degenerating cells/mm3) for different brain
regions.The numerical density counts from these brain regions were
added to give a cumulative score for degenerating cells for each
brain, and a mean was calculated for each treatment condition (𝑛 =
7–10 per group). Values are presented as mean ± SEM. ∗∗𝑃 < 0.01,

























Figure 5: Age dependency of PMA (500𝜇g/kg) induced neurode-
generation using De Olmos cupric silver staining. The numerical
density counts from brain regions were added to give a cumulative
score for degenerating cells for each brain, and a mean was
calculated for each age group (𝑛 = 8–14 per group). Values are
presented as mean ± SEM. ∗∗𝑃 < 0.01; ∗∗∗𝑃 < 0.001; one-way
analysis of variance (ANOVA) with Newman-Keul post hoc test.
microarchitecture 14 and 21 days after birth. Normal cortex
exhibits a specific cytoarchitecture and is horizontally orga-
nized into laminae and vertically into groups of synaptically
linked cells, called neocortical minicolumns. This represents
the basic processing units of the mature neocortex [18].
The cortical cytoarchitecture in animals treated with PMA
































Figure 6: Cresyl violet staining (magnification 20x) performed in 10 𝜇m-thick sections depicting disorganized cytoarchitecture of layers I
and II of the frontal cortex in 14-day-old rats subjected to vehicle (a) or PMA (500 𝜇g/kg) (b) at P6. 14- and 21-day-old rat pups treated with
PMA at P6 showed reduced total cell density in comparison with controls (c) (𝑛 = 7–11 per group). Values are presented as mean ± SEM.
∗∗
𝑃 < 0.01; ∗∗∗𝑃 < 0.001, one-way analysis of variance (ANOVA) with Newman-Keul post hoc test.
early in life was disorganized, primarily affecting layer II by
disrupting the expected arrangement of cells in layers and
columns. Analog to our results, inflammation during the
critical period of brain development induced by LPS leads
to amplified neuronal injury and impairment of synaptic
plasticity [19]. Furthermore, neonatal exposure of LPS and
oxygen revealed decreased numbers of oligodendrocytes in
the adult cortex and hippocampus [20].
PMA has been described to activate granulocytes, to
elevate levels of proinflammatory cytokines like IL-6, TNF-
𝛼, and IL-1𝛽, and to release reactive oxygen species and
glutamate as potential mechanisms of injury [10, 11, 21].
In our model, we also found a strong increase of IL-1𝛽
as a response after PMA exposure, supporting the idea of
using PMA as an activator for a systemic inflammatory
response. In addition, we used IRAK-4 and IL-18 knockout
mice to further address possible mechanisms involved in
PMA induced neurotoxicity. IRAK-4 is required for LPS-
induced activation of antigen presenting cells with IRAK-4-
deficient animals being completely resistant to LPS [22, 23].
Furthermore, animals inhibited or deficient for IRAK-4 are
protected against oxygen-mediated [6] and hypoxia-ischemia
(HI) induced neuronal injury [24]. In our experiments IRAK-
4 knockout mice treated with PMAwere protected compared
to their wild-type littermates.These results suggest that PMA
treatment does promote IRAK-4 mediated neurodegenera-
tion. An inflammatory role for IL-18 has been implicated
in several diseases including HI in the immature brain. IL-
18 is increased after HI and IL-18 deficiency has also been
shown to be protective against brain injury after neonatal HI
[25, 26]. In contrast, adult mice lacking the gene for IL-18
are not protected against ischemic injury emphasizing the
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Figure 7: Mice deficient in IRAK-4 or IL-18 are protected against
PMA-induced neurodegeneration. Six-day-old homozygous IRAK-
4 and IL-18mice were subjected to PMA (200 𝜇g/kg). Quantification
of cell death was performed on fluoro-jade B-labeled sections. IL-
18 (−/−) (𝑛 = 4) and IRAK-4 (−/−) (𝑛 = 9) deficient mice
displayed significant differences in degenerating cells compared
with their wild-type littermates (𝑛 = 6). PMA induced a strong
neurodegenerative response in wild-type mice compared to their
vehicle treated littermates. Values are presented as mean ± SEM.
∗∗∗
𝑃 < 0.001, one-way analysis of variance (ANOVA) with
Newman-Keul post hoc test.
controversy regarding the role of IL-18 in different injury
models and developmental stages [27]. In our studies, mice
deficient for IL-18 were protected against PMA toxicity
suggesting a potential role of IL-18 in PMA triggered brain
injury.
5. Conclusions
To our knowledge, this is the first study showing that systemic
PMA application during a critical period of development can
induce an inflammatory response combined with neurode-
generation and alter brain development with long-lasting
effects into adolescence.The injury is characterized by diffuse
grey matter injury with programmed cell death being a
component involved in neuronal injury. IRAK-4 and IL-
18, two major inflammatory pathways, seem to be involved
in PMA triggered brain injury. The increasing problem of
diffuse brain injury [28] raises in our opinion the need for
more subtle models of inflammation triggered brain injury.
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